相关实验视频
Updated: May 10, 2025

09:11
Assays for Validating Histone Acetyltransferase Inhibitors
Published on: August 6, 2020
6.4K
在癌症发展中HDACs的机制
Ying Zhang1, Haotian Wang1, Zhumei Zhan2
1Department of Hematology, The First Hospital of Jilin University, Changchun, China.
Frontiers in immunology
|April 22, 2025
概括
基因组脱乙酶抑制剂 (HDACis) 通过阻止细胞生长和增强免疫力,显示出作为表观遗传癌症治疗的前景. 研究重点是选择性抑制剂和组合治疗,以获得更好的精确医学结果.
科学领域:
- 表观遗传学 在表观遗传学中,表观遗传学是指表观遗传学.
- 分子生物学分子生物学
- 在瘤学瘤学.
背景情况:
- 基因组脱乙酶 (HDACs) 是表观遗传调节剂,对细胞功能至关重要.
- HDAC 抑制剂 (HDACis) 正在成为向癌症治疗的新兴药物.
- 通过细胞循环停止,细胞亡和免疫调节,HDACs表现出抗瘤作用.
研究的目的:
- 审查HDACs在瘤恶性瘤中的作用.
- 评估下一代HDACis. 的临床进展情况.
- 提供关于表观遗传向癌症药物开发的见解.
主要方法:
- 在癌症中对HDAC调节网络的系统审查.
- 对新型HDAC抑制剂的临床转化分析.
- 对抑制HDAC的组合疗法策略的评估.
主要成果:
- HDACs与各种瘤恶性病变途径有关.
- 下一代HDAC的目标是提高选择性和减少非目标效应.
- 组合疗法和特定亚型的策略是克服抗性的关键.
结论:
- 在精密瘤学方面,HDACis是一个有前途的途径.
- 对选择性HDAC抑制剂和组合策略的进一步研究是有必要的.
- 本综述为开发先进的表观遗传癌症疗法提供了一个框架.
相关概念视频
Epigenetic Regulation
2.9K
Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...
X-chromosome...
2.9K
Adaptive Mechanisms in Cancer Cells
5.5K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.5K
Histone Modification
12.8K
The histone proteins have a flexible N-terminal tail extending out from the nucleosome. These histone tails are often subjected to post-translational modifications such as acetylation, methylation, phosphorylation, and ubiquitination. Particular combinations of these modifications form “histone codes” that influence the chromatin folding and tissue-specific gene expression.
Acetylation
The enzyme histone acetyltransferase adds acetyl group to the histones. Another enzyme, histone...
Acetylation
The enzyme histone acetyltransferase adds acetyl group to the histones. Another enzyme, histone...
12.8K
Inhibition of Cdk Activity
4.6K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.6K
Spreading of Chromatin Modifications
8.1K
The histone proteins in the nucleosomes are post-translationally modified (PTM) to increase or decrease access to DNA. The commonly observed PTMs are methylation, acetylation, phosphorylation, and ubiquitination of lysine amino acids in the histone H3 tail region. These histone modifications have specific meaning for the cell. Hence, they are called "histone code". The protein complex involved in histone modification is termed as "reader-writer" complex.
Writers
The writer...
Writers
The writer...
8.1K
mTOR Signaling and Cancer Progression
3.6K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.6K

